Subtitles section Play video
-
- [Narrator] Theranos CEO Elizabeth Holmes
-
has been found guilty on four out of the 11 charges
-
related to defrauding investors,
-
and while the verdict sheds light
-
on the legal accountability of making faulty promises,
-
it actually further complicates the difference
-
between the fake-it-till-you-make-it mindset and fraud.
-
- When I heard that she was guilty,
-
I wouldn't say that I was surprised,
-
but I was interested in the way that it had broken down.
-
(dramatic music)
-
- [Narrator] The 11 charges against Elizabeth Holmes
-
fell roughly into two buckets:
-
defrauding patients and defrauding investors.
-
- She was found innocent of all of the patient stuff,
-
all three of the underlying counts
-
plus the conspiracy charge, and then on the investor side,
-
she was found guilty of conspiracy
-
and three of the charges against her,
-
and the jury hung on three other charges.
-
- [Narrator] Liz Lopatto is deputy editor at "The Verge"
-
and has been covering Theranos since 2015.
-
- We heard only a very little from the patients.
-
We heard from three patients,
-
and their testimony was maybe an hour total,
-
unlike the rest of the counts where we heard from
-
some of these people for days,
-
but there also wasn't a direct connection made
-
between Holmes and the patients,
-
and we didn't get enough about how involved Holmes was
-
with the advertising and how much she had chosen
-
to include or not include, how much of that was deliberate.
-
I think it was easier to prove the charges against
-
the investors because Holmes was literally
-
in the room with them.
-
We don't have to question where they got their information.
-
We know. - But that's not to say
-
the patients' testimony didn't aid in the final verdicts.
-
- They heard from people who were having a hard time.
-
They knew Holmes knew that people were having a hard time.
-
Stuff was getting forwarded to her for about retesting,
-
about taking certain tests off the menu.
-
The jury knew that she knew everything was not right
-
in the clinical lab even if she wasn't
-
intentionally defrauding patients.
-
It's not a great outcome for her.
-
The maximum she can be charged for each one
-
of those wire fraud counts is 20 years.
-
Now, I don't think she's going to get 20 years
-
on each one of those counts.
-
I could be wrong.
-
It's possible that she won't see jail time.
-
I don't think that's likely either.
-
I think she is probably now looking at jail.
-
- [Narrator] Over the course of the trial,
-
hundreds of people flocked to San Jose to catch a glimpse
-
of Holmes and follow the courtroom drama.
-
- There were so many people who had read "Bad Blood"
-
in their book clubs and just wanted to come see,
-
people who are just interested.
-
There was a person who worked in the biotech industry
-
and was retired, and this had been the subject
-
of huge gossip in her friend group,
-
and then there was one woman outside who was like,
-
"We love you, Elizabeth! You're a good mom,"
-
and the judge actually mentioned that doing that
-
could potentially cause a mistrial if the jurors hear you
-
and scolded her in court.
-
We watched her get up and leave. (laughs)
-
So it was a mix. We had a little bit of goofiness.
-
We had a little bit of seriousness.
-
- [Narrator] And on the stand,
-
Holmes displayed the same control and image
-
that she had become known for.
-
- In the courtroom,
-
Elizabeth home seemed immaculately controlled.
-
Her posture was perfect.
-
Even though the day was running really long,
-
you could see her lawyers starting to wilt next to her,
-
and she's sitting just like this,
-
just absolutely straight up.
-
She was pleasant. She was focused.
-
She was keeping an eye on things.
-
She was certainly engaged,
-
but she also was a little distant,
-
which again, I understand this.
-
If you're in a room full of reporters,
-
maybe you don't want to engage with us.
-
That might be the wisest move if you're on trial.
-
That's fine.
-
But the overall impression I got was
-
that she seemed like she had a tremendous amount
-
of self-possession and self control,
-
and that that was really the thing
-
that I was struck by throughout.
-
- [Narrator] But as the reality of the trial
-
began to set in, there was a shift.
-
- There was a period where she was undergoing
-
her direct questioning by her lawyers
-
where I had this impression that she was realizing
-
how serious the situation was in real time
-
as she was trying to respond to some of the things
-
that she'd heard the other witnesses saying,
-
and it was sort of horrible to have somebody realize
-
how serious things are for them when they
-
are literally on the witness stand.
-
That was sort of awful to watch.
-
I can't help but think that it was partially because
-
of this impression I got of her as somebody
-
who really prepares, who's probably an A student
-
who brought the teacher in apple who really gave
-
great testimony when she had prepared it
-
and kind of knew what she was going to say,
-
but whenever there was a question
-
that was kind of on the fly, she got nervous,
-
and she was really nervous during her cross-examination,
-
but there was certainly a kind of waiver in self-control
-
when she was testifying and had been up there
-
for a couple of hours and was clearly getting tired.
-
- [Narrator] As we await Holmes' sentencing
-
and inevitable appeals, the trial of Sunny Balwani,
-
Theranos' former president and chief operating officer,
-
is about to begin.
-
He's facing the same charges.
-
- Sunny and Elizabeth were originally
-
going to be tried together,
-
but because of her allegation of abuse
-
which was raised in sealed pretrial motions,
-
their trials were severed.
-
Now, this is actually a pretty good thing for both of them
-
because it gave them the freedom to blame each other
-
when in their separate trials.
-
Elizabeth Holmes definitely did.
-
She definitely said, "Oh, Sunny was responsible for this.
-
"Oh, Sunny was responsible for that.
-
"Oh, the financial projections that were weird?
-
"That was Sunny."
-
It wasn't super credible,
-
but I imagine he's gonna do the same thing and say,
-
"Look, she was the CEO. This was Elizabeth.
-
"This was Elizabeth.
-
"Elizabeth was the one who talked to these people.
-
"This was Elizabeth."
-
So, I imagine that's probably good for him.
-
- [Narrator] But the guilty verdict for Holmes
-
might cue us into the outcome of the case against Balwani.
-
- Finding her guilty on the conspiracy count
-
is bad news for him.
-
It suggests that there's enough evidence of the conspiracy
-
on at least one end to convict,
-
and if there's enough evidence on one end,
-
there's probably enough evidence on the other.
-
I am interested about the patient stuff.
-
He was more directly involved with the clinical lab,
-
and so that may work out differently for him,
-
but in terms of the investor counts,
-
some of these investors testified
-
that they were dealing directly with Sunny,
-
and I am curious to see how his trial is different.
-
- [Narrator] Regardless of her sentencing
-
or the outcome of Balwani's case,
-
having a CEO or COO of a company on trial
-
is a rare spectacle,
-
and it's unlikely to happen again for a long time,
-
but not necessarily because anyone will actually
-
learn anything from Theranos' mistakes.
-
- A lot of people wanna say,
-
"Well, she's not Silicon valley,"
-
and I understand that impulse because I wouldn't say
-
she's representative of Silicon Valley,
-
but she's certainly a product of it in the same way
-
that Bernie Madoff is not representative of Wall Street,
-
but he's certainly a product of it.
-
But because so many people don't seem to want to acknowledge
-
that she's even a part of this world,
-
I don't think we're gonna see a lot of behavior changes.
-
- [Narrator] And even with the verdict,
-
investors might not change their tune in investing
-
in future companies with such bold claims.
-
- We're in this very frothy period
-
where there's a lot of money available,
-
and investors really aren't doing as much
-
due diligence as they should be.
-
That worries me
-
because that's the kind of situation
-
where fraud can potentially flourish.
-
With Theranos, it just looked like a successful company
-
until all of a sudden it wasn't,
-
and I don't know how many of those kinds of things
-
are out there lurking around right now,
-
but I do find myself wondering if we're going to see changes
-
in terms of compliance or in terms of what lawyers recommend
-
to their clients as a result of that
-
because I don't see investor behavior changing.
-
I don't necessarily see founder behavior changing.
-
(soft dramatic music)